Emphysema is characterized by irreversibly enlarged airspaces and destruction of alveolar walls. One of the factors contributing to this disease pathogenesis is an elevation in extracellular matrix (ECM) degradation in the lung. Alveolar type II (ATII) cells produce and secrete pulmonary surfactants and proliferate to restore the epithelium after damage. We isolated ATII cells from control non-smokers, smokers and patients with emphysema to determine the role of NFE2 (nuclear factor, erythroidderived 2). NFE2 is a heterodimer composed of two subunits, a 45 kDa (p45 NFE2) and 18 kDa (p18 NFE2) polypeptides. Low expression of p45 NFE2 in patients with emphysema correlated with a high ECM degradation. Moreover, we found that NFE2 knockdown increased cell death induced by cigarette smoke extract. We also studied the cross talk between p45 NFE2 and DJ-1. DJ-1 protein is a redox-sensitive chaperone that protects cells from oxidative stress. We detected that cigarette smoke significantly increased p45 NFE2 levels in DJ-1 KO mice compared to wild-type mice. Our results indicate that p45 NFE2 expression is induced by exposure to cigarette smoke, has a cytoprotective activity against cell injury, and its downregulation in human primary ATII cells may contribute to emphysema pathogenesis.
Chronic obstructive pulmonary disease (COPD) is the fourth cause of death in the world and it is currently presenting a major global public health challenge 1 . It may become the fifth ranked cause of disability, affecting approximately 10% of people over 45 years 2, 3 . It is estimated that approximately 14 million people in the United States have this disease 4 . Cigarette smoke (CS) is the key source of reactive oxygen species (ROS) and the main risk factor of COPD development. There are clearly different clinical phenotypes of COPD, which also encompasses emphysema. Pulmonary emphysema is characterized by an irreversibly increased airspaces and destruction of alveolar walls. One of the factors contributing to this disease pathogenesis is an elevation in extracellular matrix (ECM) degradation in the lung 5, 6 . ROS can fragment ECM components 7 , which is an important factor in triggering lung inflammation and causing subsequent airspace enlargement 8 . It has been reported that the composition of the ECM varies among non-smokers, smokers and COPD patients 5, 9 . There is an increased activity of metalloproteinases (MMPs) in lung tissue in individuals with this disease. MMPs are proteolytic enzymes that degrade ECM components and play a role in initiating and maintaining inflammation after exposure to CS and in emphysema 6 . MMPs expression can be modulated and activated by a cell surface protein CD147 10 , which is an extracellular matrix metalloproteinase inducer (EMMPRIN). Cathepsin B belongs to cysteine proteases 11, 12 and its levels were increased in cells treated with CS 13 . Moreover, intratracheal instillation of cathepsin B induced emphysema in hamsters I (ATI) cells to restore the epithelium after damage 17 . ROS generation and elevated oxidative stress induced by CS cause alveolar epithelial cell death 18 . We have also reported human and murine primary ATII and ATI-like cell injury induced by CS in vitro and in vivo [19] [20] [21] [22] [23] . Recent findings indicate decreased ATII cell proliferation and transdifferentation to ATI cells in patients with COPD 24 . Moreover, it has been reported that ATII cell apoptosis contributes to emphysema development 24 . However, the mechanism of proteinase expression in ATII cells as a result of dysregulated antioxidant signalling, which may contribute to this disease development is not well known.
We focused on the role of a nuclear factor, erythroid-derived 2 (NFE2) in ATII cells isolated from patients with emphysema and control non-smokers and smokers. NFE2 is a heterodimer composed of two subunits, a 45 kDa (p45 NFE2) and 18 kDa (p18 NFE2) polypeptides 25 . Transcriptional activation capacity of NFE2 depends on the N-terminal region of p45 26 . Nuclear erythroid 2-related factor-2 (NRF2) is a key regulator of antioxidant defense system and activates the transcription of numerous cytoprotective genes to eliminate ROS 25, 27 . Since p45 NFE2 and NRF2 belong to Cap′N′Collar (CNC) family 25 and possess similar DNA-binding specificities, we hypothesized that p45 NFE2 will have a cytoprotective activity against ATII cell injury by CS. We have previously reported that NRF2 expression in human primary ATII cells exposed to CS is modulated by DJ-1 19 . DJ-1 protein is a redox-sensitive chaperone that protects cells from oxidative stress 28 . We have recently showed that DJ-1 overexpression has a cytoprotective effect against primary ATII cell injury induced by cigarette smoke extract and was able to restore the impaired antioxidant defense system in these cells isolated from heavy smokers 19 . Therefore, we also wanted to analyze the cross talk between p45 NFE2 and DJ-1 to determine their functional relationship in ATII cells under oxidative stress induced by CS and in emphysema. To our knowledge, this is the first study on the role of p45 NFE2 and DJ-1 in human ATII cells in this disease.
Results
High MMP9, CD147 and cathepsin B expression in human ATII cells in emphysema. Considering the role of MMP9, CD147 and cathepsin B in COPD development 6, 10, 12 , we wanted to check their intracellular levels in ATII cells and lung tissue obtained from patients with emphysema compared to control non-smokers and smokers. We found statistically significant increase in MMP9, CD147 and cathepsin B levels in ATII cells isolated from individuals with this disease compared to non-smokers by Western blotting (Fig. 1A) . We also detected higher MMP9 expression in lung tissue obtained from these patients in comparison with controls (Fig. 1B) . Increased MMP9, CD147 and cathepsin B levels in ATII cells in emphysema may suggest their contribution to alveolar wall destruction.
We also checked MMP9, CD147 and cathepsin B mRNA levels by RT-PCR in lung tissue obtained from control non-smokers, smokers and patients with emphysema (Fig. 1C) . We found significantly higher expression of CD147 and cathepsin B in patients with this disease, suggesting its regulation at the transcription level. However, we did not detect any significant difference in MMP9 mRNA expression between these groups. Our results suggest that MMP9 may be regulated at the protein level in emphysema. Downregulated p45 NFE2 expression in human ATII cells in emphysema. NFE2 is composed of two subunits p18 and p45 and may be involved in the antioxidant defense system 25 . We found significantly lower levels of p18 NFE2 and p45 NFE2 in ATII cells in emphysema compared to control non-smokers and smokers by Western blotting (Fig. 1D) . However, we did not detect significant changes in their expression in lung tissue (Fig. 1E) , which may be related to the presence of various cell types in these samples. Moreover, we analyzed p45 NFE2 mRNA expression by RT-PCR in lung tissue (Fig. 1C ) and ATII cells ( Supplementary Fig. S1 ) and did not detect changes at gene levels in emphysema compared to controls. This suggests the p45 NFE2 regulation at the posttranslational level in emphysema. We also checked expression of ADAMTSL-4, which is a member of ADAMTS (a disintegrin and metalloproteinase with thrombospondin motif-like) family 29 and has two specific DNA binding sites for a NFE2 transcription factor. We found significantly increased ADAMTSL-4 expression in ATII cells (Fig. 1D ) and lung tissue (Fig. 1E ) in emphysema in comparison with non-smokers.
Next we wanted to further determine the regulation of NFE2 expression at the protein level. We analyzed phosphorylation of tyrosine, serine and threonine residues within p45 NFE2 in ATII cells ( Fig. 2A) and lung tissue (Fig. 2B) obtained from non-smokers, smokers and emphysema patients using immunoprecipitation followed by Western blotting. We found decreased tyrosine phosphorylation within p45 NFE2 in ATII cells in smokers. However, we observed its significantly high levels in lung tissue in smokers and emphysema patients in comparison with non-smokers. We also checked tyrosine phosphorylation within p18 NFE2, however, we didn't detect significant changes. Moreover, we analyzed serine and threonine phosphorylation within p45 NFE2 in lung tissue and we didn't observe differences in their levels between these three groups ( Supplementary Fig. S2 ). The discrepancy between our results obtained from ATII cells and lung tissue may have been caused by the presence of various cell types in latter samples.
P45 NFE2 has a cytoprotective activity. We wanted to further determine the function of p45 NFE2 in cells. We knocked down NFE2 in A549 cells using siRNA strategy ( Supplementary Fig. S3 ) followed by treatment with CSE. Cell death was analyzed by staining with Annexin V and PI (Fig. 3A) . We found significantly higher cell death in A549 cells with NFE2 knockdown followed by exposure to CSE compared to control (Fig. 3B) . Our results indicate that NFE2 knockdown sensitizes A549 cells to injury induced by CSE.
P45 NFE2 interacts with DJ-1 in human primary ATII cells. It has been reported that DJ-1 has a cytoprotective activity 28 . We have recently showed that it also modulates the antioxidant defense system regulated by NRF2 19 . Therefore, here we wanted to determine the association between DJ-1 and p45 NFE2. We immunoprecipitated DJ-1 followed by Western blotting analysis and determined p18 NFE2 and p45 NFE2 expression in lung tissue and ATII cells obtained from control non-smokers, smokers or patients with emphysema. We did not . Protein levels were analyzed by Western blotting. Densitometric analysis is also shown. *Statistically significant difference (p < 0.05) is shown for comparison between non-smokers and smokers, between smokers and emphysema patients and between non-smokers and emphysema patients. Data are shown as the mean (±s.e.m.). detect significant p18 NFE2 and DJ-1 interaction in ATII cells and lung tissue (Fig. 4A,B; Supplementary Fig. S4 ). However, we observed significantly lower p45 NFE2 and DJ-1 interaction in ATII cells isolated from patients with emphysema compared to control non-smokers or smokers. We also used immunohistofluorescence to determine p45 NFE2 and DJ-1 expression in ATII cells identified by SP-A staining (Fig. 4C) . First, we found cytoplasmic co-localization of p45 NFE2 and DJ-1. Second, we detected their lower expression and co-localization in ATII cells in emphysema compared to controls, which correlates with our results obtained by immunoprecipitation and Western blotting. Our results suggest that low p45 NFE2 and DJ-1 interaction in ATII cells in emphysema may contribute to decreased antioxidant defense system in this disease. We confirmed our findings by assessing NRF2 levels and observed its lowest expression in these patients ( Supplementary Fig. S5 ). We selected NRF2, since first, it is involved in the antioxidant defense system 27 , second, we have previously shown that DJ-1 modulates NRF2 levels 19 , and third, NRF2 and p45 NFE2 belong to Cap'N'Collar (CNC) family 25 . P45 NFE2 expression in DJ-1 KO mice exposed to CS. We further investigated the association between p45 NFE2 and DJ-1 under oxidative stress induced by CS in vivo. We used lung tissue obtained from wild-type and DJ-1 KO mice exposed to 150 mg/m 3 CS for 3 weeks. We analyzed p45 NFE2, p18 NFE2, MMP9, CD147, cathepsin B and ADAMTSL-4 expression by Western blotting. We have not observed any significant changes in these protein expression in wild type mice exposed to CS compared to control (Fig. 5A) . However, we found significantly higher expression of p45 NFE2 and CD147 in DJ-1 KO mice exposed to CS in comparison with control mice (Fig. 5B) . Interestingly, we also detected that CS significantly increased p45 NFE2 levels in DJ-1 KO mice compared to wild type mice (Supplementary Fig. S6 ). Our results suggest a compensatory function of p45 NFE2 in the absence of DJ-1. We didn't observe changes in MMP9, ADAMTSL-4 and cathepsin B expression in lung tissue in DJ-1 KO mice. We also wanted to determine p45 NFE2 levels in murine ATII cells by immunohistofluorescence. We found higher p45 NFE2 expression in ATII cells in DJ-1 KO mice exposed to CS compared to control or wild-type mice (Fig. 5C ), which correlates with our data obtained by Western blotting.
We also analyzed MMP9, CD147, cathepsin B, p45 NFE2 and ADAMTSL-4 expression by RT-PCR in lung tissue obtained from wild-type mice and DJ-1 KO mice exposed to CS. This exposure did not increase their levels in wild-type mice compared to control (Fig. 5D) . However, we found significantly higher p45 NFE2 and CD147 levels in DJ-1 KO mice exposed to CS (Fig. 5E) . We did not observe changes in MMP9, ADAMTSL-4 and cathepsin B levels in DJ-1 KO mice. These data correlate with our results obtained from Western blotting.
We observed co-localization of p45 NFE2 and DJ-1 in ATII cells in wild-type mice by immunohistoflurescence ( Supplementary Fig. S7 ). We also found higher DJ-1 expression after exposure to cigarette smoke. Furthermore, we analyzed murine ATII cell apoptosis using PARP staining by immunohistofluorescence and observed higher cell apoptosis in DJ-1 KO mice than wild-type mice exposed to cigarette smoke ( Supplementary Fig. S8 ). Our results confirm the interplay between p45 NFE2 and DJ-1 under oxidative stress induced by CS. They also suggest that induction of p45 NFE2 may compensate the absence of DJ-1. 
Discussion
Emphysema involves irreversible damage of the alveolar wall, alveolar epithelial cell death and ECM degradation 2, 30 . However, there are very limited reports on isolated ATII cells obtained from patients with this disease. Therefore, here we focused on the mechanism of dysregulated antioxidant defense system in human primary ATII cells, which may contribute to an impaired proteinase-antiproteinase balance and emphysema development.
We concentrated on the cytoprotective role of p45 NFE2 against ATII cell injury induced by CS. We used ATII cells isolated from control non-smoker and smoker organ donors and patients with emphysema. Lower expression of p45 NFE2 in patients with this disease may correlate with a high ECM degradation as detected by an elevation of MMP9, CD147 and cathepsin B in ATII cells. Our results are in agreement with observations that MMP9 can alter ECM and induce progressive airspace enlargement leading to emphysema development [31] [32] [33] [34] [35] . It has been reported that CD147 was increased in bronchoalveolar lavage fluid obtained from COPD patients, which may suggest its modulatory role in MMP9 activation 10 . Previously published studies indicate that cathepsin B mediates human alveolar epithelial cell death stimulated by lipopolysaccharides 36 and executing fetal ATII cell death induced by ROS generated by hyperoxia 37 . Our results suggest that cathepsin B may contribute to ATII cell injury under high oxidative stress induced by CS and in emphysema as well. ADAMTSL-4 (also known as TSRC1) belongs to metalloproteinase family however, its function remains largely unknown. We found its significantly higher expression in ATII cells and lung tissue obtained from smokers and patients with emphysema compared to non-smokers. ADAMTSL-4 expression may be related to percent parenchyma in patients with COPD and lung cancer 38 . In addition, it has been reported that ADAMTSL-4 interacted with cathepsin B in OV-90 cell line and its overexpression induced cell apoptosis 29 . Of note, the promotor region of ADAMTSL-4 has two specific DNA binding sites for a NFE2 transcription factor. This indicates that ADAMTSL-4 expression may be regulated by NFE2. Our data suggest that ADAMTSL-4 may be involved in emphysema pathogenesis, however its role remain to be further elucidated. P45 NFE2 and NRF2 have similar DNA-binding specificities 25 . We previously reported that NRF2 has a cytoprotective activity against human and murine primary ATII and ATI-like cell injury induced by CS 19, 22, 23 . Here we hypothesized that p45 NFE2 also provides cytoprotection against oxidative stress in ATII cells. We found significantly lower expression of p45 NFE2 in ATII cells isolated from patients with emphysema in comparison with control smokers and non-smokers by Western blotting. We further studied the functional role of NFE2 in vitro. We found that NFE2 knockdown increased cell death induced by CSE as detected by Annexin V and PI staining and flow cytometry analysis. Our findings are supported by observations that p45 NFE2 was identified as a regulator of cytoprotective genes in megakaryocytes 25 . It was reported that low ROS levels in cells are maintained mainly by NRF2 induction. However, P45 NFE2 competes with NRF2 and can maintain moderate expression of the cytoprotective genes. Moreover, p45 NFE2 KO mice have decreased expression of genes involved in a response to oxidative stress 39 . This indicates that p45 NFE2 has a cytoprotective function; however it has a weaker activity than NRF2. This is in agreement with our previous studies showing strong activation of antioxidant defense system regulated by NRF2 in ATII cells in response to oxidative stress induced by CSE and influenza virus 21, 22, 40 . Furthermore, it has been reported that NFE2 activity can be affected by posttranslational modifications such as phosphorylation 41 . Therefore, we also analyzed p45 NFE2 phosphorylation to further determine its function in ATII cells. We found statistically significant decreased phosphorylation of tyrosine within p45 NFE2 in ATII cells isolated from control smokers. Our results are in agreement with previous observations showing that inhibition of tyrosine phosphorylation augments the enhancer activity of the NFE2 function 42 . This suggests its cytoprotective role against ATII cell injury in smokers.
We have previously shown that DJ-1 modulates expression of NRF2 and downstream cytoprotective genes in human primary ATII cells exposed to CSE in vitro or isolated from heavy smokers 19 . Therefore, here we wanted to checked for the first time the association between DJ-1 and p45 NFE2. We found the lowest interaction between p45 NFE2 and DJ-1 in ATII cells isolated from emphysema patients, which correlates with decreased p45 NFE2 expression in these individuals. To further study the functional role of p45 NFE2 and DJ-1 interaction, we used lung tissue obtained from wild-type and DJ-1 KO mice exposed to CS. First, we found that CS significantly increased p45 NFE2 levels in DJ-1 KO mice after 3 weeks of exposure. This suggests that the absence of DJ-1 affects p45 NFE2 expression under oxidative stress. Second, p45 NFE2 levels in DJ-1 KO mice exposed to CS were significantly higher compared to wild-type mice, which indicates that p45 NFE2 may compensate the lack of cytoprotective DJ-1. Third, we also found increased expression of CD147 in DJ-1 KO mice. The functional link between CD147 and NFE2 has been already reported by Schultz et al. 43 in vascular inflammation in vivo. Fourth, we didn't observe differences in MMP9, cathepsin B and ADAMTSL-4 levels in wild-type and DJ-1 KO mice. This indicates that higher concentration and/ or longer exposure to CS may be required for their induction. In summary, our results suggest that oxidative stress by CS induces p45 NFE2 expression, which activates a cytoprotection against cell injury (Fig. 6 ). P45 NFE2 downregulation in human primary ATII cells may contribute to emphysema pathogenesis. Targeting p45 NFE2 may provide a potential therapeutic strategy against oxidative stress-induced lung injury.
Methods
ATII cell isolation from control organ donors and patients with emphysema. We obtained tissue from de-identified control non-smoker and smoker organ donors whose lungs were not suitable for transplantation and donated for medical research from the Gift of Life Donor Program. We selected donors with a clinical history and x-ray that did not indicate infection, reasonable lung function with a PaO 2 /FIO 2 ratio of > 250, and limited time on a ventilator. Non-smokers were individuals who never smoked and smokers smoked 10-20 cigarettes per day for at least 3 years. We also obtained tissue from patients with emphysema (GOLD IV) from lung volume reduction surgery through Temple Biobank (Temple University, Philadelphia, PA). ATII cells were isolated as we previously described (N = 14 per group) 23 . Briefly, after elastase (Worthington, Lakewood, NJ) instillation, lung was minced and the cells were filtrated and purified by centrifugation on density gradients made of Optiprep (Accurate Chemical Scientific Corp., Westbury, NY) followed by negative selection with CD14-coated magnetic beads (Dynal Biotech Western Blotting and Immunoprecipitation. GAPDH and NRF2 antibodies were obtained from Abcam (Cambridge, MA) and β-actin was purchased from Sigma-Aldrich (St. Louis, MO). The following antibodies were obtained from Santa Cruz Biotechnology (Santa Cruz, CA): MMP9, CD147, ADAMTSL-4, p45 NFE2, p18 NFE2, DJ-1, phosphoserine, phosphothreonine and phosphotyrosine. Lung tissue used for Western blotting was homogenized in Tissue PE-LB buffer (G-Biosciences, Saint Louis, MO) and ATII and A549 cells were lysed in Mammalian Cell PE buffer (G-Biosciences) with protease and phosphatase inhibitors (Gold Biotechnology, St. Louis, MO). Western blotting was performed as we previously described 19 . Briefly, cell or tissue lysates were analyzed for protein expression using polyacrylamide gradient gels (8-16%; Thermo Fisher Scientific, Waltham, MA). Nitrocellulose membrane was used for protein transfer, followed by blocking with 5% bovine serum albumin and incubation with primary antibodies overnight at 4 °C. On the following day, membranes were incubated for 1 h with horseradish peroxidase (HRP)-conjugated AffiniPure donkey anti-rabbit IgG or HRP-conjugated AffiniPure donkey anti-mouse IgG purchased from Jackson ImmunoResearch (West Grove, PA). The blots were developed using Luminata Forte Western HRP Substrate (Millipore, Billerica, MA) for chemiluminescent detection of protein expression. The density of bands was quantified using ImageJ and NIH Image 1.62 software (Bethesda, MD). For immunoprecipitation, the lung tissue was homogenized and ATII cells were lysed as described above and p45 NFE2, p18 NFE2 or DJ-1 antibodies were added to the lysate overnight. The immunoprecipitates were collected by incubating with Protein A/G Plus Agarose beads (Santa Cruz Biotechnology, CA) for 2 h. The beads bearing the immunoprecipitates were washed three times with PBS and used for Western blotting as described above.
RT-PCR. RT -PCR was used to analyze human and murine MMP9, CD147, ADAMTSL-4, cathepsin B and p45 NFE2 mRNA expression. Gene-specific primers were retrieved from PrimerBank (http://pgamgh.harvard. edu/primerbank/) and ordered from Invitrogen (Waltham, MA). The sequences of the primers are provided in Supplementary Table S1 . ATII cells were lysed and lung tissue was homogenized in RLT buffer (Qiagen, Germantown, MD). Total RNA was isolated from these samples using Quick-RNA MiniPrep (Zymo Research, Irvine, CA). A total of 1 µg total RNA was reverse transcribed into cDNA using the SuperScript IV First-Strand Synthesis System (Thermo Fisher Scientific, Waltham, MA) according to the manufacturer's recommendations. mRNA expression was determined by RT-PCR using the SYBR Green Master Mix (Applied Biosystems, Foster 
